Allegion PLC has a consensus price target of $125.83 based on the ratings of 13 analysts. The high is $155 issued by Atlantic Equities on November 29, 2021. The low is $100 issued by Vertical Research on October 19, 2023. The 3 most-recent analyst ratings were released by Wells Fargo, Barclays, and Barclays on July 25, 2024, July 25, 2024, and July 10, 2024, respectively. With an average price target of $122 between Wells Fargo, Barclays, and Barclays, there's an implied -10.80% downside for Allegion PLC from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/25/2024 | Buy Now | 0.17% | Wells Fargo | Joseph O'Dea | $125 → $137 | Maintains | Equal-Weight | Get Alert |
07/25/2024 | Buy Now | -14.45% | Barclays | Julian Mitchell | $112 → $117 | Maintains | Underweight | Get Alert |
07/10/2024 | Buy Now | -18.11% | Barclays | Julian Mitchell | $116 → $112 | Maintains | Underweight | Get Alert |
07/10/2024 | Buy Now | -8.61% | Wells Fargo | Joseph O'Dea | $141 → $125 | Maintains | Equal-Weight | Get Alert |
06/04/2024 | Buy Now | -15.19% | Barclays | Julian Mitchell | $122 → $116 | Downgrade | Equal-Weight → Underweight | Get Alert |
04/16/2024 | Buy Now | -3.49% | UBS | Chris Snyder | $113 → $132 | Maintains | Neutral | Get Alert |
04/02/2024 | Buy Now | -10.8% | Barclays | Julian Mitchell | $121 → $122 | Maintains | Equal-Weight | Get Alert |
02/23/2024 | Buy Now | 3.09% | Mizuho | Brett Linzey | $140 → $141 | Downgrade | Buy → Neutral | Get Alert |
02/21/2024 | Buy Now | -11.53% | Barclays | Julian Mitchell | $119 → $121 | Maintains | Equal-Weight | Get Alert |
02/21/2024 | Buy Now | 2.36% | Wells Fargo | Joseph O'Dea | $139 → $140 | Downgrade | Overweight → Equal-Weight | Get Alert |
12/19/2023 | Buy Now | 1.63% | Wells Fargo | Joseph O'Dea | $119 → $139 | Maintains | Overweight | Get Alert |
12/04/2023 | Buy Now | -12.99% | Barclays | Julian Mitchell | $130 → $119 | Downgrade | Overweight → Equal-Weight | Get Alert |
10/19/2023 | Buy Now | -26.88% | Vertical Research | Jeffrey Sprague | $128 → $100 | Downgrade | Buy → Hold | Get Alert |
09/06/2023 | Buy Now | — | Longbow Research | David Macgregor | — | Downgrade | Buy → Neutral | Get Alert |
07/27/2023 | Buy Now | -7.14% | Morgan Stanley | Joshua Pokrzywinski | $120 → $127 | Maintains | Equal-Weight | Get Alert |
07/12/2023 | Buy Now | -12.26% | Morgan Stanley | Joshua Pokrzywinski | $120 → $120 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
07/10/2023 | Buy Now | -4.95% | Barclays | Julian Mitchell | $120 → $130 | Maintains | Overweight | Get Alert |
05/01/2023 | Buy Now | -4.95% | Wells Fargo | Joe O'Dea | $116 → $130 | Maintains | Overweight | Get Alert |
04/27/2023 | Buy Now | -12.99% | Morgan Stanley | Joshua Pokrzywinski | $120 → $119 | Maintains | Equal-Weight | Get Alert |
04/27/2023 | Buy Now | -7.87% | Baird | Timothy Wojs | $130 → $126 | Maintains | Neutral | Get Alert |
04/14/2023 | Buy Now | -12.99% | Goldman Sachs | Joe Ritchie | $138 → $119 | Maintains | Buy | Get Alert |
04/13/2023 | Buy Now | -15.19% | Wells Fargo | Joseph O'Dea | $130 → $116 | Maintains | Overweight | Get Alert |
04/06/2023 | Buy Now | -12.26% | Barclays | Julian Mitchell | $129 → $120 | Maintains | Overweight | Get Alert |
02/23/2023 | Buy Now | -6.41% | Mizuho | Brett Linzey | $123 → $128 | Maintains | Buy | Get Alert |
02/23/2023 | Buy Now | -12.99% | Morgan Stanley | Joshua Pokrzywinski | $108 → $119 | Maintains | Equal-Weight | Get Alert |
02/06/2023 | Buy Now | -3.49% | Baird | Timothy Wojs | $116 → $132 | Maintains | Neutral | Get Alert |
01/19/2023 | Buy Now | -4.95% | Wells Fargo | Joe O'Dea | $121 → $130 | Maintains | Overweight | Get Alert |
01/13/2023 | Buy Now | -10.07% | Mizuho | Brett Linzey | $114 → $123 | Maintains | Buy | Get Alert |
01/06/2023 | Buy Now | -21.04% | Morgan Stanley | Joshua Pokrzywinski | $107 → $108 | Maintains | Equal-Weight | Get Alert |
01/05/2023 | Buy Now | -11.53% | Wells Fargo | Joe O'Dea | $116 → $121 | Maintains | Overweight | Get Alert |
01/05/2023 | Buy Now | -5.68% | Barclays | Julian Mitchell | $127 → $129 | Maintains | Overweight | Get Alert |
01/03/2023 | Buy Now | -6.41% | Vertical Research | Jeffrey Sprague | → $128 | Upgrade | Hold → Buy | Get Alert |
12/01/2022 | Buy Now | -7.14% | Barclays | Julian Mitchell | $118 → $127 | Maintains | Overweight | Get Alert |
10/28/2022 | Buy Now | -21.77% | Morgan Stanley | Joshua Pokrzywinski | $98 → $107 | Maintains | Equal-Weight | Get Alert |
10/28/2022 | Buy Now | -15.19% | Wells Fargo | Joseph O'Dea | $114 → $116 | Maintains | Overweight | Get Alert |
10/28/2022 | Buy Now | -15.19% | Credit Suisse | John Walsh | $108 → $116 | Maintains | Neutral | Get Alert |
10/12/2022 | Buy Now | -28.35% | Morgan Stanley | Joshua Pokrzywinski | $117 → $98 | Maintains | Equal-Weight | Get Alert |
10/03/2022 | Buy Now | -15.92% | Barclays | Julian Mitchell | $125 → $115 | Maintains | Overweight | Get Alert |
09/21/2022 | Buy Now | -16.65% | Mizuho | Brett Linzey | $125 → $114 | Maintains | Buy | Get Alert |
08/01/2022 | Buy Now | -16.65% | Wells Fargo | Joseph O'Dea | $115 → $114 | Maintains | Overweight | Get Alert |
07/29/2022 | Buy Now | -14.45% | Morgan Stanley | Joshua Pokrzywinski | $115 → $117 | Maintains | Equal-Weight | Get Alert |
07/18/2022 | Buy Now | -15.19% | Baird | Timothy Wojs | $120 → $116 | Maintains | Neutral | Get Alert |
07/18/2022 | Buy Now | -8.61% | Mizuho | Brett Linzey | $145 → $125 | Maintains | Buy | Get Alert |
07/13/2022 | Buy Now | -15.92% | Wells Fargo | Joseph O'Dea | $118 → $115 | Maintains | Overweight | Get Alert |
07/11/2022 | Buy Now | -19.57% | B of A Securities | Andrew Obin | $130 → $110 | Downgrade | Neutral → Underperform | Get Alert |
07/08/2022 | Buy Now | -8.61% | Barclays | Julian Mitchell | $140 → $125 | Maintains | Overweight | Get Alert |
07/06/2022 | Buy Now | -12.26% | Baird | Timothy Wojs | $135 → $120 | Maintains | Neutral | Get Alert |
06/29/2022 | Buy Now | -13.72% | Wells Fargo | Joe O'Dea | $130 → $118 | Maintains | Overweight | Get Alert |
06/23/2022 | Buy Now | -17.38% | Goldman Sachs | Joe Ritchie | $140 → $113 | Maintains | Buy | Get Alert |
05/31/2022 | Buy Now | -15.92% | Morgan Stanley | Joshua Pokrzywinski | $120 → $115 | Maintains | Equal-Weight | Get Alert |
04/27/2022 | Buy Now | -7.14% | Credit Suisse | John Walsh | $132 → $127 | Maintains | Neutral | Get Alert |
04/27/2022 | Buy Now | -12.26% | Morgan Stanley | Joshua Pokrzywinski | $130 → $120 | Maintains | Equal-Weight | Get Alert |
04/27/2022 | Buy Now | -4.95% | Wells Fargo | Joseph O'Dea | $132 → $130 | Maintains | Overweight | Get Alert |
04/20/2022 | Buy Now | -1.29% | Baird | Timothy Wojs | $140 → $135 | Maintains | Neutral | Get Alert |
04/07/2022 | Buy Now | -3.49% | Wells Fargo | Joseph O'Dea | $147 → $132 | Maintains | Overweight | Get Alert |
04/07/2022 | Buy Now | -4.95% | Morgan Stanley | Joshua Pokrzywinski | $134 → $130 | Maintains | Equal-Weight | Get Alert |
04/07/2022 | Buy Now | 0.17% | Goldman Sachs | Joe Ritchie | $153 → $137 | Maintains | Buy | Get Alert |
04/04/2022 | Buy Now | 9.67% | Barclays | Julian Mitchell | $160 → $150 | Maintains | Overweight | Get Alert |
02/16/2022 | Buy Now | -2.03% | Morgan Stanley | Joshua Pokrzywinski | $146 → $134 | Maintains | Equal-Weight | Get Alert |
02/16/2022 | Buy Now | -2.03% | Credit Suisse | John Walsh | $142 → $134 | Maintains | Neutral | Get Alert |
02/16/2022 | Buy Now | 6.02% | Mizuho | Brett Linzey | $170 → $145 | Maintains | Buy | Get Alert |
02/16/2022 | Buy Now | 7.48% | Wells Fargo | Joseph O'Dea | $157 → $147 | Maintains | Overweight | Get Alert |
12/17/2021 | Buy Now | 24.3% | Mizuho | Brett Linzey | — | Initiates | → Buy | Get Alert |
12/08/2021 | Buy Now | 3.82% | B of A Securities | Andrew Obin | — | Downgrade | Buy → Neutral | Get Alert |
11/29/2021 | Buy Now | 13.33% | Atlantic Equities | Richard Radbourne | — | Initiates | → Overweight | Get Alert |
10/22/2021 | Buy Now | 6.75% | Morgan Stanley | Joshua Pokrzywinski | — | Maintains | Equal-Weight | Get Alert |
10/08/2021 | Buy Now | 16.25% | Wells Fargo | Joseph O'Dea | — | Initiates | → Overweight | Get Alert |
10/07/2021 | Buy Now | 0.17% | Morgan Stanley | Joshua Pokrzywinski | — | Maintains | Equal-Weight | Get Alert |
10/04/2021 | Buy Now | 24.3% | Barclays | Julian Mitchell | — | Maintains | Overweight | Get Alert |
09/10/2021 | Buy Now | 27.22% | Goldman Sachs | Joe Ritchie | — | Upgrade | Neutral → Buy | Get Alert |
The latest price target for Allegion (NYSE:ALLE) was reported by Wells Fargo on July 25, 2024. The analyst firm set a price target for $137.00 expecting ALLE to rise to within 12 months (a possible 0.17% upside). 14 analyst firms have reported ratings in the last year.
The latest analyst rating for Allegion (NYSE:ALLE) was provided by Wells Fargo, and Allegion maintained their equal-weight rating.
The last upgrade for Allegion PLC happened on January 3, 2023 when Vertical Research raised their price target to $128. Vertical Research previously had a hold for Allegion PLC.
The last downgrade for Allegion PLC happened on June 4, 2024 when Barclays changed their price target from $122 to $116 for Allegion PLC.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Allegion, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Allegion was filed on July 25, 2024 so you should expect the next rating to be made available sometime around July 25, 2025.
While ratings are subjective and will change, the latest Allegion (ALLE) rating was a maintained with a price target of $125.00 to $137.00. The current price Allegion (ALLE) is trading at is $136.77, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.